A nurse is caring for a client who is participating in a research study for an experimental chemotherapy medication. After three treatments, the experimental medication is discontinued due to evidence of rapidly advancing kidney failure. Which of the following ethical principles was demonstrated?
A.
Veracity.
B.
Autonomy.
C.
Nonmaleficence.
D.
Fidelity.
The Correct answer and Explanation is:
The correct answer is C. Nonmaleficence.
Explanation:
Nonmaleficence is a fundamental ethical principle in healthcare that obligates healthcare providers to avoid causing harm to patients. In the context of this scenario, the nurse is involved in caring for a client who is part of a research study for an experimental chemotherapy medication. After administering three treatments, the medication is discontinued due to evidence of rapidly advancing kidney failure. This situation exemplifies the principle of nonmaleficence in several ways.
Firstly, the decision to discontinue the experimental medication reflects a commitment to the client’s well-being. The healthcare team recognized that the chemotherapy was causing harm—specifically, it was contributing to the deterioration of the client’s kidney function. By halting the treatment, the team acted to prevent further harm, aligning with the principle of nonmaleficence, which emphasizes the importance of minimizing potential risks and adverse effects associated with medical interventions.
Secondly, this situation also highlights the importance of monitoring and assessing the risks associated with experimental treatments. In clinical trials, the safety of participants is paramount, and researchers are ethically obligated to discontinue treatment if serious adverse effects are identified. The swift action taken to withdraw the medication demonstrates adherence to ethical standards, prioritizing patient safety over the continuation of a potentially harmful intervention.
While other principles such as veracity (truthfulness), autonomy (respecting the patient’s right to make informed decisions), and fidelity (keeping promises and commitments) are also vital in healthcare, the immediate action of discontinuing a harmful treatment in response to the evidence of kidney failure most clearly embodies the principle of nonmaleficence. This principle ultimately underscores the healthcare provider’s responsibility to safeguard patients from harm, especially in the context of experimental treatments where risks may be heightened.